Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial.

---

Autoria(s): Moreau P.; Hulin C.; Marit G.; Caillot D.; Facon T.; Lenain P.; Berthou C.; Pégourié B.; Stoppa A.M.; Casassus P.; Michallet M.; Benboubker L.; Maisonneuve H.; Doyen C.; Leyvraz S.; Mathiot C.; Avet-Loiseau H.; Attal M.; Harousseau J.L.; IFM group

Data(s)	2010
Identificador	https://serval.unil.ch/?id=serval:BIB_9DFB8E873129 isbn:1476-5551[electronic], 0887-6924[linking] pmid:20428201 doi:10.1038/leu.2010.82 isiid:000278575400022
Idioma(s)	en
Fonte	Leukemia, vol. 24, no. 6, pp. 1233-1235
Palavras-Chave	#Boronic Acids/therapeutic use; Dexamethasone/therapeutic use; Drug Therapy, Combination; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukapheresis/methods; Multiple Myeloma/therapy; Pyrazines/therapeutic use; Stem Cell Transplantation; Transplantation, Autologous
Tipo	info:eu-repo/semantics/article article